key: cord-0975793-cxloop2j authors: Vizheh, Maryam; Muhidin, Salut; Aghajani, Faezeh; Maleki, Zohreh; Bagheri, Fereshteh; Hosamirudsari, Hadiseh; Aleyasin, Ashraf; Tehranian, Afsaneh title: Characteristics and outcomes of COVID‐19 pneumonia in pregnancy compared with infected nonpregnant women date: 2021-04-19 journal: Int J Gynaecol Obstet DOI: 10.1002/ijgo.13697 sha: a2661bc64a1072fc00f876e2a7662a82c30bd5d3 doc_id: 975793 cord_uid: cxloop2j OBJECTIVE: To compare the clinical and paraclinical features and outcomes of pregnant and nonpregnant women with COVID‐19. METHODS: A multicenter retrospective cohort study of pregnant and nonpregnant women of reproductive age hospitalized between March and October 2020 in Tehran, Iran. Medical records were reviewed and women who tested positive for SARS‐CoV‐2 on RT‐PCR were included. Extracted data were compared and logistic regression performed. RESULTS: A total of 110 pregnant and 234 nonpregnant COVID‐19‐positive women were included. Frequency of severe disease was higher in nonpregnant women than pregnant women (29% vs 11.8%; P < 0.001). Symptoms including cough, dyspnea, chill, fatigue, and headache were more frequent in nonpregnant women (P < 0.05). Pregnant women had higher oxygen saturation levels and lower lymphocyte count (P = 0.001). Six (5.5%) pregnant and 12 (5.1%) nonpregnant women died (P = 0.80). No significant differences between the groups were found for ICU admission and end organ failure. Significantly more nonpregnant women had acute respiratory distress syndrome (ARDS, 9.4% vs 0%; P = 0.001). Univariate regression indicated association between hypertension and death; oxygen saturation and ARDS; and body mass index and ICU admission. No association was found between pregnancy and death, ICU admission, or ARDS. CONCLUSION: Pregnant women with COVID‐19 are not at higher risk of adverse outcomes compared with nonpregnant women. Quantitative variables are described using mean ± SD or median. Categorical variables are summarized as frequency and percentage. Pregnant and nonpregnant women of reproductive age were compared using the t test for continuous variables and χ 2 or Fisher exact test for categorical variables. Logistic regression was performed to examine the relationship between pregnancy, underlying diseases, age, and COVID-19 outcomes. Statistical analyses were performed using SPSS version 21.0 (IBM Corp., Armonk, NY, USA). P < 0.05 was considered statistically significant. A total of 4391 COVID-19 patients were admitted to the three hospitals over the study period. After excluding male patients, women older than 45 years, and women younger than 15 years, 344 women were included, of whom 110 were pregnant and 234 were nonpregnant women of reproductive age (31.98% vs 68.02%). The mean age of pregnant and nonpregnant women was similar (32.02 ± 6.1 [IQR, vs 32.88 ± 6.3 [IQR ; P = 0.241) ( Table 1) . For pregnant women, mean gestational age was 32 weeks plus 1 day (range, 6 weeks to 41 weeks plus 1 day). Although high in both groups, prevalence of comorbidities was higher in pregnant women (51.8% vs 22.2%; P < 0.001) ( Table 1) . For clinical findings, in both groups most patients had moderate disease ( Table 1 ). The frequency of severe disease was higher in nonpregnant women compared with pregnant women (29% vs 11.8%; P < 0.001). The two groups did not differ significantly in length of time from onset of symptoms to hospitalization (5.26 ± 4.19 days vs 6.19 ± 4.79 days; P = 0.244). Data for this variable were only available for 49 pregnant and 107 nonpregnant patients. The most frequent symptom reported by pregnant women was fever (n = 60, 54.5%), followed by cough (n = 42, 38.2%) and myalgia (n = 30, 27.3%). In nonpregnant women the most common symptom was cough (n = 164, 70.1%), followed by dyspnea (n = 140, 59.8%) and fever (n = 110, 47%). Cough, dyspnea, chill, fatigue, headache, vomiting, loss of appetite, and chest pain were significantly more frequent in nonpregnant women compared with pregnant women (P < 0.05). In contrast, anosmia and runny nose were significantly more frequent in pregnant women compared with nonpregnant women (P = 0.001). There were no differences between the groups for frequency of fever, myalgia, weakness, diarrhea, and nausea ( 26.4% vs 1.7%, P < 0.001, respectively) ( Table 2) . Of the 110 pregnant women, 5 (4.5%) were in the postpartum period. The remaining 105 women had a gestational age of between 6 weeks and 40 weeks +1 day with a median of 32 weeks +1 day. The majority (n = 67, 60.9%) were in the third trimester ( Given the lack of data on the effect of COVID-19 on pregnancy outcomes, 8 The results of the present study showed that initial symptoms in pregnant women are different compared with nonpregnant women. Fever was the most observed symptom in pregnant women compared with cough in nonpregnant women. Higher peripheral oxygen saturation level and lymphopenia at the time of admission were more common in pregnant women. Duration of hospitalization was significantly shorter in pregnant women. Although the rate of underlying disease in both groups was significant, death in both groups was similar. The most common adverse pregnancy outcomes were increased cesarean section, fetal distress, preterm labor, low birth weight, and neonatal intensive care unit admission. The results of the present study show some differences and similarities with previous studies. In contrast to our findings, the large sample-size study by Ellington et al. 9 reported fever as the most common symptom in both pregnant and nonpregnant women. Moreover, other studies have reported that fever was not underpinned as a common symptom in pregnant women. 10 our study, just one of eight infected neonates delivered vaginally. Therefore, we cannot answer whether it was possible to get the infection during vaginal delivery. However, it provides support to restrict cesarean section to obstetric indications. Studies from China with high COVID-19 cases reported a higher rate of cesarean section, no association between pregnancy and severity of disease and length of hospital stay, 16 more frequent abnormal CT scan, and similar outcomes compared with nonpregnant women. 17 A large study of 326 335 women of reproductive age (15- 44 years), of which 8207 (9.0%) were pregnant, concluded that pregnant women are more likely to be admitted to the ICU or receive mechanical ventilation, but the risk of mortality is not increased. 9 A study from Sweden reported that the risk of admission to the ICU is higher in pregnant women than nonpregnant women. 18 In the present study, the rate of ICU admission was higher in pregnant women although the difference between the groups was not significant. We believe these results should be interpreted cautiously. In many areas with a high incidence of infection or inadequate supplies, such as Iran, only patients with severe or critical disease would be hospitalized. At The present study has some strengths and limitations. In contrast to many previous studies that included pregnant women only in late pregnancy, our study included women in all trimesters. Furthermore, most studies had a small sample size. A limitation of the present study is its retrospective design, which exposes our results to potential bias. Another limitation is that we did not include patients who were not hospitalized, which may generate bias in generalizability of findings. In conclusion, the clinical and paraclinical presentations of pregnant women are different from nonpregnant women. Although there were no significant differences between the two groups for mortality, ICU admission, and end organ failure, the rate of ARDS in pregnant women was lower. Moreover, a considerable rate of obstetric complications and neonatal consequences was observed. The authors have no conflicts of interest. MV, SM, and AT contributed to study concept and design and manuscript writing. FA, ZM, FB, HH, and AA contributed to acquisition, analysis, or interpretation of data. All authors approved the final version of manuscript. WHO declares COVID-19 a pandemic Emerging infections and pregnancy Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review Laboratory characteristics of pregnant compared to non-pregnant women infected with SARS-CoV-2 Characteristics of COVID-19 infection in Beijing Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status-United States Clinico-radiological features and outcomes in pregnant women with COVID-19 pneumonia compared with age-matched non-pregnant women Analysis of maternal coronavirus infections and neonates born to mothers with 2019-nCoV; a systematic review Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: a systematic review and metaanalysis Maternal and neonatal outcomes of pregnant women with coronavirus disease 2019 (COVID-19) pneumonia: a case-control study Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review Characteristics and outcomes of pregnant women hospitalised with confirmed SARS-CoV-2 infection in the UK: a national cohort study using the UK Obstetric Surveillance System (UKOSS) Coronavirus disease 2019 in pregnancy Clinico-radiological features and outcomes in pregnant women with COVID-19: compared with age-matched non-pregnant women Public Health Agency of Sweden's Brief Report: pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden A postpartum death due to coronavirus disease 2019 (COVID-19) in the United States Maternal mortality and COVID-19 Asymptomatic coronavirus infection among pregnant women: a necessity for universal screening of COVID-19 in pregnant women admitted to labor Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals Characteristics and outcomes of COVID-19 pneumonia in pregnancy compared with infected nonpregnant women